Doctor Maria Rita Lima

Mavacamten in a real-world hypertrophic cardiomyopathy population: how many may be eligible?

Event: ESC Congress 2024

Topic: Hypertrophic Cardiomyopathy

Session: Cardiac myosin inhibitors for treatment of hypertrophic obstructive cardiomyopathy

Access

Like

Long-term clinical and imaging outcomes of patients undergoing percutaneous femoral intervention following TAVI-related vascular access complications

Event: ESC Congress 2024

Topic: Aortic Valve Intervention

Session: TAVI: common and unusual complications and their management

Access

Like

LV reverse remodeling after SAVR in patients with severe symptomatic aortic stenosis: impact on the clinical outcome

Event: ESC Congress 2024

Topic: Valvular Heart Disease

Session: Exploring valvular and congenital heart disease with cardiac magnetic resonance

Access

Like

Non-invasive structured remote telemonitoring in advanced heart failure: a single-centre experience

Event: Heart Failure 2024

Topic: Remote Patient Monitoring and Telehealth

Session: ePosters in e-cardiology/digital health 6

Access

Like

Mavacamten in a real-world hypertrophic cardiomyopathy population: how many may be eligible?

Event: Heart Failure 2024

Topic: Hypertrophic Cardiomyopathy

Session: Cardiomyopathies: present and future

Access

Like

Cardiac damage extent in patient with isolated severe aortic stenosis referred to surgical aortic valve replacement: is it reversible after surgery?

Event: ESC Congress 2023

Topic: Aortic Valve Stenosis

Session: Valvular disease and myocardial remodelling: a dangerous liaison

Access

Like

Long-term prognosis of elderly patients undergoing atrial septum defect closure: are we acting too late?

Event: ESC Congress 2023

Topic: Cardiovascular Disease in the Elderly

Session: Heart disease in the elderly: treatment and outcomes

Access

Like

Validation and potential usefulness of the updated PROMISE minimal risk tool in patients with suspected coronary artery disease undergoing coronary CT angiography

Event: ESC Congress 2023

Topic: Noninvasive Diagnostic Methods

Session: Diagnostic and imaging methods in coronary artery disease

Access

Like

Is myocardial fibrosis appropriately assessed by 2D strain derived integrated backscatter?

Event: ESC Congress 2023

Topic: Valvular Heart Disease

Session: New technologies and artificial intelligence in ultrasound

Access

Like

Validation and potential usefulness of the updated PROMISE Minimal Risk Tool in patients with suspected coronary artery disease undergoing coronary CT angiography

Event: EACVI 2023

Topic: Coronary Computed Tomography Angiography (Coronary CTA, CCTA)

Session: Computerised tomography angiography in the heart of cardioavascular imaging

Access

Like

Doctor Maria Rita Lima

Contributor content

Mavacamten in a real-world hypertrophic cardiomyopathy population: how many may be eligible?

Long-term clinical and imaging outcomes of patients undergoing percutaneous femoral intervention following TAVI-related vascular access complications

LV reverse remodeling after SAVR in patients with severe symptomatic aortic stenosis: impact on the clinical outcome

Non-invasive structured remote telemonitoring in advanced heart failure: a single-centre experience

Mavacamten in a real-world hypertrophic cardiomyopathy population: how many may be eligible?

Cardiac damage extent in patient with isolated severe aortic stenosis referred to surgical aortic valve replacement: is it reversible after surgery?

Long-term prognosis of elderly patients undergoing atrial septum defect closure: are we acting too late?

Validation and potential usefulness of the updated PROMISE minimal risk tool in patients with suspected coronary artery disease undergoing coronary CT angiography

Is myocardial fibrosis appropriately assessed by 2D strain derived integrated backscatter?

Validation and potential usefulness of the updated PROMISE Minimal Risk Tool in patients with suspected coronary artery disease undergoing coronary CT angiography

ESC 365 is supported by

Doctor Maria Rita Lima Follow

Contributor content

Mavacamten in a real-world hypertrophic cardiomyopathy population: how many may be eligible?

Long-term clinical and imaging outcomes of patients undergoing percutaneous femoral intervention following TAVI-related vascular access complications

LV reverse remodeling after SAVR in patients with severe symptomatic aortic stenosis: impact on the clinical outcome

Non-invasive structured remote telemonitoring in advanced heart failure: a single-centre experience

Mavacamten in a real-world hypertrophic cardiomyopathy population: how many may be eligible?

Cardiac damage extent in patient with isolated severe aortic stenosis referred to surgical aortic valve replacement: is it reversible after surgery?

Long-term prognosis of elderly patients undergoing atrial septum defect closure: are we acting too late?

Validation and potential usefulness of the updated PROMISE minimal risk tool in patients with suspected coronary artery disease undergoing coronary CT angiography

Is myocardial fibrosis appropriately assessed by 2D strain derived integrated backscatter?

Validation and potential usefulness of the updated PROMISE Minimal Risk Tool in patients with suspected coronary artery disease undergoing coronary CT angiography

ESC 365 is supported by

Doctor Maria Rita Lima